Raphael Pharmaceutical (RAPH) Cash from Financing Activities (2020 - 2025)
Raphael Pharmaceutical's Cash from Financing Activities was -$4,000 in Q4 2025, compared with $41,000 a year earlier.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Cash from Financing Activities (2020 - 2025) Analysis & Trends
For FY2025, Cash from Financing Activities at Raphael Pharmaceutical came in at $236,000, down 26.5% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $321,000 in FY2024 (-72.0%), $1.15 million in FY2023 (+27.8%), $896,000 in FY2022 (-39.3%) and $1.48 million in FY2021 (+79.2%).
- The Q4 2025 figure marks the lowest quarterly Cash from Financing Activities in data going back to Q4 2020.
- Compared with a year earlier, Cash from Financing Activities was higher in three of the last four quarters, with growth averaging 23.0%.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q3 2023 (growth of 515.2%); the worst was Q4 2023 (a decline of 96.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.18 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 230,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 288,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 472,000.00 |
| Sep 30, 2022 | 112,000.00 |
| Jun 30, 2022 | 302,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 820,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 513,000.00 |
| Mar 31, 2021 | 44,000.00 |
| Dec 31, 2020 | 527,000.00 |
API Access
Raphael Pharmaceutical Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RAPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RAPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RAPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();